EE9900543A - Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool - Google Patents
Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsoolInfo
- Publication number
- EE9900543A EE9900543A EEP199900543A EEP9900543A EE9900543A EE 9900543 A EE9900543 A EE 9900543A EE P199900543 A EEP199900543 A EE P199900543A EE P9900543 A EEP9900543 A EE P9900543A EE 9900543 A EE9900543 A EE 9900543A
- Authority
- EE
- Estonia
- Prior art keywords
- bioavailability
- protease inhibitor
- hiv protease
- oral absorption
- sulphate salt
- Prior art date
Links
- 229940122440 HIV protease inhibitor Drugs 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900543A true EE9900543A (et) | 2000-06-15 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900543A EE9900543A (et) | 1997-05-29 | 1998-05-26 | Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (is) |
| JP (1) | JP3267632B2 (is) |
| KR (1) | KR20010013042A (is) |
| CN (1) | CN1257497A (is) |
| AU (1) | AU730245B2 (is) |
| BG (1) | BG103923A (is) |
| BR (1) | BR9809498A (is) |
| CA (1) | CA2291086A1 (is) |
| EA (1) | EA199901095A1 (is) |
| EE (1) | EE9900543A (is) |
| HR (1) | HRP980283A2 (is) |
| HU (1) | HUP0004621A3 (is) |
| ID (1) | ID23858A (is) |
| IL (1) | IL132779A0 (is) |
| IS (1) | IS5240A (is) |
| NO (1) | NO995822L (is) |
| PE (1) | PE75099A1 (is) |
| PL (1) | PL336847A1 (is) |
| SK (1) | SK163299A3 (is) |
| TR (1) | TR199902816T2 (is) |
| TW (1) | TW438799B (is) |
| WO (1) | WO1998054178A1 (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642237B1 (en) | 1999-11-24 | 2003-11-04 | Merck & Co., Inc. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof |
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3000564B2 (ja) * | 1993-12-15 | 2000-01-17 | メルク エンド カンパニー インコーポレーテッド | Ｈｉｖプロテアーゼ阻害剤 |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/zh active
- 1998-05-26 ID IDW991462A patent/ID23858A/id unknown
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 CN CN98805372A patent/CN1257497A/zh active Pending
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/hu unknown
- 1998-05-26 PL PL98336847A patent/PL336847A1/xx unknown
- 1998-05-26 IL IL13277998A patent/IL132779A0/xx unknown
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/xx unknown
- 1998-05-26 EE EEP199900543A patent/EE9900543A/xx unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/pt not_active Application Discontinuation
- 1998-05-26 JP JP50079999A patent/JP3267632B2/ja not_active Expired - Fee Related
- 1998-05-26 SK SK1632-99A patent/SK163299A3/sk unknown
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/ko not_active Withdrawn
- 1998-05-26 EA EA199901095A patent/EA199901095A1/ru unknown
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Ceased
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/hr not_active Application Discontinuation
- 1998-05-28 PE PE1998000432A patent/PE75099A1/es not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/is unknown
- 1999-11-24 BG BG103923A patent/BG103923A/xx unknown
- 1999-11-26 NO NO995822A patent/NO995822L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004621A2 (hu) | 2002-03-28 |
| KR20010013042A (ko) | 2001-02-26 |
| CA2291086A1 (en) | 1998-12-03 |
| WO1998054178A1 (en) | 1998-12-03 |
| PE75099A1 (es) | 1999-08-11 |
| BG103923A (en) | 2000-06-30 |
| BR9809498A (pt) | 2000-06-20 |
| CN1257497A (zh) | 2000-06-21 |
| PL336847A1 (en) | 2000-07-17 |
| NO995822D0 (no) | 1999-11-26 |
| TW438799B (en) | 2001-06-07 |
| HRP980283A2 (en) | 1999-08-31 |
| HUP0004621A3 (en) | 2002-04-29 |
| IS5240A (is) | 1999-11-09 |
| AU730245B2 (en) | 2001-03-01 |
| IL132779A0 (en) | 2001-03-19 |
| EA199901095A1 (ru) | 2000-08-28 |
| EP0986554A1 (en) | 2000-03-22 |
| NO995822L (no) | 2000-01-28 |
| ID23858A (id) | 2000-05-25 |
| JP2000513747A (ja) | 2000-10-17 |
| AU7595998A (en) | 1998-12-30 |
| SK163299A3 (en) | 2000-07-11 |
| JP3267632B2 (ja) | 2002-03-18 |
| TR199902816T2 (xx) | 2000-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000725A (et) | Uued 3-arüülpropaanhappe derivaadid ja nende analoogid | |
| NL300952I2 (nl) | Peramivir en farmaceutisch aanvaardbare zouten daarvan | |
| FI960635L (fi) | Elektrodi ja sen valmistus | |
| DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
| EE200100258A (et) | Antraniilhappe amiidid ja nende kasutamine ravimitena | |
| DE69823016D1 (de) | Wässrige lösungen von salicylsaure derivaten | |
| CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
| EE200100022A (et) | Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon | |
| EE200000798A (et) | HIV proteaasi inhibiitori bisulfaatsool | |
| DE69502726D1 (de) | Hestellung von aniontensidgranulaten | |
| EE200100632A (et) | Amlodipiini ja atorvastatiini ühine sool | |
| FI970317A7 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| EP1009377A4 (en) | MEDICAL USE OF PYRUVATES | |
| EE200200146A (et) | Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon | |
| EE200000506A (et) | Meta-asatsüklilised aminobensoehappeühendid ja nende derivaadid integriini antagonistidena | |
| DE69907146T2 (de) | Direkte oxidation von cycloalkanen | |
| FI971711L (fi) | Levobupivakaiinin ja sen analogien kiteyttäminen | |
| DE69508812D1 (de) | Sulfoniumsalz und chemisch verstärkte Positivresistzusammensetzungen | |
| PT878467E (pt) | Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos | |
| FI956116A7 (fi) | N-fosfonometyyliglysiinin ja sen suolojen valmistus | |
| EE9900543A (et) | Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool | |
| ID24327A (id) | Produksi senyawa-senyawa avermektin | |
| EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
| DE69400693D1 (de) | Minderung von NOx-Emissionen | |
| FI962019A7 (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina ainein a |